Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

por Herman, SEM, Barr, PM, McAuley, EM, Liu, D, Wiestner, A, Friedberg, JW
Publicado 2013

P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS

por Wiestner, A., Baskar, S., Peng, H., Gaglione, E., Lindorfer, M., Taylor, R., Rader, C.
Publicado 2022